ChemoCentryx: 3Q Earnings Snapshot

Associated Press |

MOUNTAIN VIEW, Calif. (AP) _ ChemoCentryx Inc. (CCXI) on Thursday reported a loss of $10.9 million in its third quarter.

The Mountain View, California-based company said it had a loss of 22 cents per share.

The results surpassed Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 25 cents per share.

The biopharmaceutical company posted revenue of $9 million in the period, which fell short of Street forecasts. Three analysts surveyed by Zacks expected $11.6 million.

ChemoCentryx shares have increased 97 percent since the beginning of the year. In the final minutes of trading on Thursday, shares hit $11.70, a climb of 51 percent in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CCXI at https://www.zacks.com/ap/CCXI

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
XOM

     

Level Headed at World Crypto Con - Steve Beauregard

Bloq.com CRO Steve Beauregard joins Jack Brewer at World Crypto Con.

Emerging Growth

DirectView Holdings Inc

DirectView Holdings Inc designs and installs surveillance systems, digital video recording and services. The company through its subsidiaries operates within two divisions security and surveillance and video conferencing services.